>
Spotlight February 2021: Nanoobjects in the COVID-vaccine – scientifically correct?
The COVID-19 pandemic induces very different reactions of people on the internet (https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e1.htm) and in the social networks. Without following the conspiracy theories as “5G nanochip hidden in COVID vaccines” some news as “COVID vaccines induce allergic reactions” should be scientifically recognised. The picture from the 5G-nanochip whose plan goes viral on the internet is now exposed as fake and shows a guitar pedal. Quite different the recent news about allergic responses after injection of the COVID vaccine [1-3]. Is it true, and how about nanoparticles in vaccines?
Firstly, we should know that the active ingredient within the new vaccines are very sensitive molecules (the so-called mRNA) which must not only be cooled during transport but also would immediately be degraded after injection if not explicitly be stabilized by a special nano-shell. Here the principles of nanomedicine are adopted as the instable RNA-molecule is packed into a lipid layer containing stabilizing polymers (e.g. polyethylene glycol = PEG and others) [4, 5]. These polymers are part of the transport system which delivers the active agent to the cells in our body which start the anti-viral machinery. Unfortunately, such molecules may have a disadvantage because a small part of the population responds sensitive to polymers such as PEG which has been observed in 12 patients after getting the vaccine [1, 3]. The portion of sensitive people is very small but not negligible (currently more than 32 Mio. people have been vasccinated, as of January 2021), thus, it is important to know about the ingredients [please find the full list of the two recent vaccines in 3] and to discuss these with the treating physician. Scientific fact is: the size of the lipid vesicles (nano) is not of importance in relation to adverse effects. Ingredients such as the polymers of the shell around the active agent may induce problems, but the advantage of a COVID vaccination is indisputable.
If someone wants to know more about nanoparticles and vaccination, please visit the website of the Helmholtz Centre for Infection Research: https://www.helmholtz-hzi.de/en/news-events/stories/vaccination-with-nanoparticles/ .
Literature:
- de Vrieze, J (2021) Pfizer’s vaccine raises allergy concerns. Science, 371(6524): 10-11.
- Kleine-Tebbe, J et al. (2021) Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences. Allergol Select, 5 26-28.
- Worm, M et al. (2021) Covid-19 vaccination and risk of anaphylaxis – Recommendations for practical management. MMW Fortschr Med, 163(1): 48-51.
- Editorial (2020) Nanomedicine and the COVID-19 vaccines. Nat Nanotechnol, 15(12): 963
- Abd Ellah, NH et al. (2020) Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine (Lond), 15(21): 2085-2102.
Weitere Spotlights
Spotlight April 2023: Recycling rare earths – bacteria assist in the circular economy
Rare earths are important components of wind turbines, catalytic converters, fibre optic cables and plasma screens. Since the 17 metals grouped under this term are indispensable for modern technologies, demand and costs are constantly rising. The occurrence of productive mining sites is limited and the production is often costly and environmentally harmful. The advantages of […]
Read moreSpotlight July: Plastic Pollution and the Urgent Need for Comprehensive Action
Plastic pollution has become a significant threat to the oceans, biodiversity, and ecosystems worldwide. Despite efforts to reduce plastic consumption, escalating plastic production continues to increase the magnitude of plastic pollution in the environment. In response to this crisis, the UN-Environmental Assembly (Link) adopted a resolution in March 2022 to develop a legally binding treaty […]
Read moreSpotlight September: A methodology for the automatic evaluation of data quality and completeness of nanomaterials for risk assessment purposes
This paper describes a method for automatically assessing the quality and completeness of nanosafety data for the purpose of risk assessment. Steps to develop the methodology for assessing data completeness and the methodology for assessing quality are presented. The methodology is tailored to physicochemical and hazard (meta) data, but can also be configured with appropriate […]
Read moreSpotlight January 2022: Methods, models, mechanisms and metadata
For the new year, we are presenting no “classic” paper here, but would like to point out an editorial: Methods, Models, Mechanisms and Metadata: Introduction to the Nanotoxicology Collection at F1000 Research. This editorial introduces the F1000Research Nanotoxicology Collection, where best practices can be collected in the form of original research reports, including no-effect studies, […]
Read more


